The first study this month is from @jhlt.bsky.social and explores the safety and efficacy of #istaroxime in patients with pre- #cardiogenicshock due to #AcuteHF. It's reviewed by Sumita Barua of St. Vincent's in Sydney.
We'll highlight the rest of the studies later this month.
We'll highlight the rest of the studies later this month.
August 25, 2025 at 3:58 PM
The first study this month is from @jhlt.bsky.social and explores the safety and efficacy of #istaroxime in patients with pre- #cardiogenicshock due to #AcuteHF. It's reviewed by Sumita Barua of St. Vincent's in Sydney.
We'll highlight the rest of the studies later this month.
We'll highlight the rest of the studies later this month.